Kurume Central Hospital Operator to File for Bankruptcy; Known for Liver Cancer Treatment – Nishinippon Shimbun ME

News Highlights

The medical corporation operating “Kurume Central Hospital” in Kurume City, Fukuoka Prefecture, began preparations for bankruptcy proceedings on October 30th. The hospital was well-regarded for its liver cancer treatment but appears to have fallen into financial difficulties. The aging of the chairman and director, and the lack of a successor are considered to have made continued operation difficult. This case suggests that exploring options for business succession, rather than closure, should have been considered.

M&A Medical Editorial Department’s Perspective

The news that the operating corporation of Kurume Central Hospital is preparing to file for bankruptcy highlights the harsh realities facing regional medical care. Even a hospital that had gained a certain reputation in a highly specialized field like liver cancer treatment faces the risk of closure due to issues of succession and business sustainability. This is not a distant problem for healthcare facility managers. The fact that the chairman and director are around 60 years old, an age when individuals typically begin to seriously consider business succession, indicates the necessity of preparation with a relatively long-term perspective of 5 to 10 years. Utilizing specialized advisors focused on the medical industry can lead to solutions for more fundamental issues, such as financial improvement, organizational restructuring, and the establishment of a new management system, beyond mere procedural support.

Points Raised by This News

• The reality that even with a track record in specialized medical care, the absence of a successor can directly lead to a crisis for hospital survival.
• Delays in preparing for business succession from around the age of 60 for the chairman and director can be fatal.
• Urgent consideration of third-party succession, other than closure or discontinuation of business, is necessary to minimize the impact on regional medical care.
• Early engagement with specialized advisors is key to the success of medical M&A and business succession.

Practical Questions Arising from This News

• If a successor cannot be found, what specific third-party succession schemes can be considered?
• Should business succession have been considered much earlier, before preparations for bankruptcy proceedings began?
• Is it possible to proceed with business succession while maintaining specialization, such as in liver cancer treatment?

If You Feel “Should I Consult Too?”

The case of Kurume Central Hospital serves as a prompt for managers and directors who are concerned about future succession issues and business continuity at their own medical institutions to seek consultation early. Particularly if the chairman or director is over 60, a successor candidate is not clearly identified, or there are no signs of improvement in the business situation, it is time to explore the possibilities of third-party succession with experts to avoid the worst-case scenario of closure or discontinuation of business.

M&A Medical (CentralMedience Inc.) supports the business succession of medical corporations, hospitals, and clinics on a full success fee basis as a certified M&A support institution by the Small and Medium Enterprise Agency. Consultations are accepted with strict confidentiality. Free consultation here